skip to content
Textbook of bladder cancer Preview this item
ClosePreview this item
Checking...

Textbook of bladder cancer

Author: Seth P Lerner; Mark P Schoenberg; Cora N Sternberg
Publisher: Abingdon, Oxon, UK ; Boca Raton, FL : Taylor & Francis, 2006.
Edition/Format:   Print book : EnglishView all editions and formats
Summary:
Bladder cancer is the fifth most common cancer of American men and the eighth most common cancer of American women, with sixty thousand new cases of the disease diagnosed each year in the US alone. Disease prevalence is high in western nations due to the predominance of the chronic relapsing form of cancer that occurs in these countries (USA prevalence estimated to be 600,000; NCI-SEER database), and this single  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Document Type: Book
All Authors / Contributors: Seth P Lerner; Mark P Schoenberg; Cora N Sternberg
ISBN: 1841843822 9781841843827
OCLC Number: 61129709
Description: xvii, 786 pages : illustrations (some color) ; 29 cm
Contents: Epidemiology of bladder cancer --
Occupational risk factors --
Familial bladder cancer --
Genetic susceptibility to bladder cancer --
Urothelial carcinoma and its variants --
WHO/ISUP grading system --
Urothelial bladder tumor pathology: contemporary consensus classification and diagnosis based on the World Health Organization (WHO) 1973 classification --
Non-urothelial tumors --
Gene discovery (overview) --
Molecular biology of bladder cancer: cell cycle alterations --
Cytogenetics of urothelial neoplasis --
Gene microarrays --
Molecular biology of invasive and metastatic urothelial cancer --
Animal models of bladder cancer --
Animal models: naturally ocurring canine urinary bladder cancer --
Cystoscopy --
Floresence endoscopy --
Imaging in the assessment of urinary bladder carcinoma --
Cytology and DNA ploidy --
Voided urine markers --
Staging --
Etiology and management of urothelial tumors of the renal pelvis and ureter --
Early detection for bladder cancer --
Natural history of stages Ta, T1, and Tis urothelial cancer in the urinary bladder --
Risk stratification of Ta, Tis, T1 cancer --
Issues in staging of Ta, Tis, T1 bladder cancers --
Transurethral resection of bladder tumors --
Laser ablation and other technology --
Perioperative instillation of chemotherapeutic drugs --
The role of intravesical chemotherapy in the treatment of bladder cancer: optimization and novel agents --
Intravesical chemotherapy of superficial bladder cancer: --
Intravesical immunotherapy: BCG --
Mode of action of BCG and rationale for combination immunotherapy --
Marker tumor concept: ethical issues --
The use of the marker tumor concept in Ta, T1 bladder cancer: is it justified? --
Photodynamic therapy --
G3T1 bladder carcinoma --
What to do when BCG fails --
Chemoprevention of superficial bladder cancer --
Surrogate endpoint biomarkers --
Follow-up strategies in superficial bladder cancer --
The natural history of invasive bladder cancer --
Selection and perioperative management of patients undergoing radical cystectomy and urinary reconstruction --
Radical cystectomy --
technique and outcomes --
Cystectomy in the female --
Nerve-sparing radical cystectomy --
Laparoscopic radical cystectomy and urinary diversion --
Role of extended pelvic lymphadenectomy --
Role of sentinel node detection --
Management of the urethra in the cystectomy patient --
Role of radical cystectomy in patients with unresectable and/or locoregionally metastatic bladder cancer --
Radical TURBT --
Partial cystectomy --
Optimal radiotherapy for bladder cancer --
Trimodality therapy in the management of muscle-invasive bladder cancer: a selective organ-preserving approach --
Orthotopic neobladder --
Continent cutaneous diversion --
Noncontinent urinary diversion --
Metabolic aspects of diversion --
Psychosocial and quality-of-life issues --
Tissue engineering of the bladder --
Clinical trial design --
Neo-adjuvant chemotherapy in the treament of muscle-invasive bladder cancer --
Adjuvant chemotherapy for invasive bladder cancer --
Treatment of metastic cancer --
Special considerations in the elderly patient --
Targeted therapy for bladder cancer --
Bladder cancer gene therapy --
Treatment of non-TCC adenocarcinoma/sarcoma --
Treatment of squamous cell carcinoma --
Pediatric bladder tumours --
Bladder cancer internet resources --
Support groups --
Education and counseling of the cystectomy patient.
Responsibility: edited by Seth P. Lerner, Mark P. Schoenberg, and Cora N. Sternberg.

Abstract:

Textbook of Bladder Cancer  Read more...

Reviews

Editorial reviews

Publisher Synopsis

"a comprehensive reference which draws on the expertise of an international community of prominent bladder cancer experts. Fully illustrated, the textbook includes chapters on both scientific and Read more...

 
User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/61129709> # Textbook of bladder cancer
    a schema:Book, schema:CreativeWork ;
   library:oclcnum "61129709" ;
   library:placeOfPublication <http://id.loc.gov/vocabulary/countries/enk> ;
   library:placeOfPublication <http://experiment.worldcat.org/entity/work/data/355047931#Place/abingdon_oxon_uk> ; # Abingdon, Oxon, UK
   library:placeOfPublication <http://experiment.worldcat.org/entity/work/data/355047931#Place/boca_raton_fl> ; # Boca Raton, FL
   schema:about <http://experiment.worldcat.org/entity/work/data/355047931#Topic/blasenkrebs> ; # Blasenkrebs
   schema:about <http://id.worldcat.org/fast/834067> ; # Bladder--Cancer
   schema:about <http://experiment.worldcat.org/entity/work/data/355047931#Topic/blaaskanker> ; # Blaaskanker
   schema:about <http://experiment.worldcat.org/entity/work/data/355047931#Topic/urinary_bladder_neoplasms> ; # Urinary Bladder Neoplasms
   schema:about <http://id.loc.gov/authorities/subjects/sh2009117264> ; # Bladder--Cancer
   schema:about <http://dewey.info/class/616.99462/e22/> ;
   schema:bookFormat bgn:PrintBook ;
   schema:contributor <http://viaf.org/viaf/166296855> ; # Seth P. Lerner
   schema:contributor <http://viaf.org/viaf/164323569> ; # Mark P. Schoenberg
   schema:contributor <http://viaf.org/viaf/20012669> ; # Cora N. Sternberg
   schema:datePublished "2006" ;
   schema:description "Epidemiology of bladder cancer -- Occupational risk factors -- Familial bladder cancer -- Genetic susceptibility to bladder cancer -- Urothelial carcinoma and its variants -- WHO/ISUP grading system -- Urothelial bladder tumor pathology: contemporary consensus classification and diagnosis based on the World Health Organization (WHO) 1973 classification -- Non-urothelial tumors -- Gene discovery (overview) -- Molecular biology of bladder cancer: cell cycle alterations -- Cytogenetics of urothelial neoplasis -- Gene microarrays -- Molecular biology of invasive and metastatic urothelial cancer -- Animal models of bladder cancer -- Animal models: naturally ocurring canine urinary bladder cancer -- Cystoscopy -- Floresence endoscopy -- Imaging in the assessment of urinary bladder carcinoma -- Cytology and DNA ploidy -- Voided urine markers -- Staging -- Etiology and management of urothelial tumors of the renal pelvis and ureter -- Early detection for bladder cancer -- Natural history of stages Ta, T1, and Tis urothelial cancer in the urinary bladder -- Risk stratification of Ta, Tis, T1 cancer -- Issues in staging of Ta, Tis, T1 bladder cancers -- Transurethral resection of bladder tumors -- Laser ablation and other technology -- Perioperative instillation of chemotherapeutic drugs -- The role of intravesical chemotherapy in the treatment of bladder cancer: optimization and novel agents -- Intravesical chemotherapy of superficial bladder cancer: -- Intravesical immunotherapy: BCG -- Mode of action of BCG and rationale for combination immunotherapy -- Marker tumor concept: ethical issues -- The use of the marker tumor concept in Ta, T1 bladder cancer: is it justified? -- Photodynamic therapy -- G3T1 bladder carcinoma -- What to do when BCG fails -- Chemoprevention of superficial bladder cancer -- Surrogate endpoint biomarkers -- Follow-up strategies in superficial bladder cancer -- The natural history of invasive bladder cancer -- Selection and perioperative management of patients undergoing radical cystectomy and urinary reconstruction -- Radical cystectomy -- technique and outcomes -- Cystectomy in the female -- Nerve-sparing radical cystectomy -- Laparoscopic radical cystectomy and urinary diversion -- Role of extended pelvic lymphadenectomy -- Role of sentinel node detection -- Management of the urethra in the cystectomy patient -- Role of radical cystectomy in patients with unresectable and/or locoregionally metastatic bladder cancer -- Radical TURBT -- Partial cystectomy -- Optimal radiotherapy for bladder cancer -- Trimodality therapy in the management of muscle-invasive bladder cancer: a selective organ-preserving approach -- Orthotopic neobladder -- Continent cutaneous diversion -- Noncontinent urinary diversion -- Metabolic aspects of diversion -- Psychosocial and quality-of-life issues -- Tissue engineering of the bladder -- Clinical trial design -- Neo-adjuvant chemotherapy in the treament of muscle-invasive bladder cancer -- Adjuvant chemotherapy for invasive bladder cancer -- Treatment of metastic cancer -- Special considerations in the elderly patient -- Targeted therapy for bladder cancer -- Bladder cancer gene therapy -- Treatment of non-TCC adenocarcinoma/sarcoma -- Treatment of squamous cell carcinoma -- Pediatric bladder tumours -- Bladder cancer internet resources -- Support groups -- Education and counseling of the cystectomy patient."@en ;
   schema:description "Bladder cancer is the fifth most common cancer of American men and the eighth most common cancer of American women, with sixty thousand new cases of the disease diagnosed each year in the US alone. Disease prevalence is high in western nations due to the predominance of the chronic relapsing form of cancer that occurs in these countries (USA prevalence estimated to be 600,000; NCI-SEER database), and this single fact makes bladder cancer one of the most expensive cancers to treat. This volume is a comprehensive reference drawing on the expertise of an international community of experts in the area. All aspects of disease biology, diagnosis and treatment are addressed."@en ;
   schema:exampleOfWork <http://worldcat.org/entity/work/id/355047931> ;
   schema:inLanguage "en" ;
   schema:name "Textbook of bladder cancer"@en ;
   schema:productID "61129709" ;
   schema:publication <http://www.worldcat.org/title/-/oclc/61129709#PublicationEvent/abingdon_oxon_uk_boca_raton_fl_taylor_&_francis_2006> ;
   schema:publisher <http://experiment.worldcat.org/entity/work/data/355047931#Agent/taylor_&_francis> ; # Taylor & Francis
   schema:workExample <http://worldcat.org/isbn/9781841843827> ;
   umbel:isLike <http://bnb.data.bl.uk/id/resource/GBA561118> ;
   wdrs:describedby <http://www.worldcat.org/title/-/oclc/61129709> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/355047931#Agent/taylor_&_francis> # Taylor & Francis
    a bgn:Agent ;
   schema:name "Taylor & Francis" ;
    .

<http://experiment.worldcat.org/entity/work/data/355047931#Place/abingdon_oxon_uk> # Abingdon, Oxon, UK
    a schema:Place ;
   schema:name "Abingdon, Oxon, UK" ;
    .

<http://experiment.worldcat.org/entity/work/data/355047931#Topic/urinary_bladder_neoplasms> # Urinary Bladder Neoplasms
    a schema:Intangible ;
   schema:name "Urinary Bladder Neoplasms"@en ;
    .

<http://id.loc.gov/authorities/subjects/sh2009117264> # Bladder--Cancer
    a schema:Intangible ;
   schema:name "Bladder--Cancer"@en ;
    .

<http://id.worldcat.org/fast/834067> # Bladder--Cancer
    a schema:Intangible ;
   schema:name "Bladder--Cancer"@en ;
    .

<http://viaf.org/viaf/164323569> # Mark P. Schoenberg
    a schema:Person ;
   schema:familyName "Schoenberg" ;
   schema:givenName "Mark P." ;
   schema:name "Mark P. Schoenberg" ;
    .

<http://viaf.org/viaf/166296855> # Seth P. Lerner
    a schema:Person ;
   schema:familyName "Lerner" ;
   schema:givenName "Seth P." ;
   schema:name "Seth P. Lerner" ;
    .

<http://viaf.org/viaf/20012669> # Cora N. Sternberg
    a schema:Person ;
   schema:familyName "Sternberg" ;
   schema:givenName "Cora N." ;
   schema:name "Cora N. Sternberg" ;
    .

<http://worldcat.org/isbn/9781841843827>
    a schema:ProductModel ;
   schema:isbn "1841843822" ;
   schema:isbn "9781841843827" ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.